Cargando…

Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancer

BACKGROUND: This study aimed to assess the longitudinal health-related quality of life (HRQOL) using the Expanded Prostate Cancer Index Composite (EPIC) and HRQOL change between the nerve-sparing technique in Japanese men treated with robot-assisted radical prostatectomy (RARP). METHODS: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuda, Kazuhiro, Muto, Satoru, China, Toshiyuki, Koyasu, Hiroki, Noma, Yasuhiro, Ashizawa, Takeshi, Hirano, Hisashi, Kitamura, Kosuke, Shimizu, Fumitaka, Nagata, Masayoshi, Isotani, Shuji, Horie, Shigeo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042679/ https://www.ncbi.nlm.nih.gov/pubmed/35510095 http://dx.doi.org/10.1016/j.prnil.2021.08.001

Ejemplares similares

Port site hernia at the robotic arm port after robotic‐assisted laparoscopic radical prostatectomy
por: Ogasa, Taiki, et al.
Publicado: (2020)

The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non–muscle‑invasive Bladder Cancer
por: Muto, Satoru, et al.
Publicado: (2021)

Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
por: Nagaya, Naoya, et al.
Publicado: (2020)

Significant association between urethral length measured by magnetic resonance imaging and urinary continence recovery after robot-assisted radical prostatectomy
por: Kitamura, Kosuke, et al.
Publicado: (2019)

Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men
por: Isotani, Shuji, et al.
Publicado: (2023)

Robot-Assisted Radical Cystectomy with Modified Vesica Ileale Padovana (VIP) Neobladder Configuration Using a Hybrid Approach: Initial Experience
por: Shimizu, Fumitaka, et al.
Publicado: (2023)

Successful wound closure using fibrin glue for intractable neobladder‐urethral anastomosis leakage after radical cystectomy and neobladder reconstruction
por: Ishikawa, Keisuke, et al.
Publicado: (2023)

Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases
por: Hirano, Hisashi, et al.
Publicado: (2023)

A preliminary oncologic outcome and postoperative complications in patients undergoing robot-assisted radical cystectomy: Initial experience
por: Muto, Satoru, et al.
Publicado: (2017)

Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer
por: Ashizawa, Takeshi, et al.
Publicado: (2022)

Efficacy and Safety of 5-Aminolevulinic Acid for Patients with Symptoms of Late-Onset Hypogonadism: A Preliminary Study
por: Koyasu, Hiroki, et al.
Publicado: (2022)

Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens
por: Kitamura, Kosuke, et al.
Publicado: (2014)

Robot-assisted partial nephrectomy for T1b renal cell carcinoma with complete situs inversus totalis with pre- and intraoperative three-dimensional virtual imaging
por: Yazaki, Haruka, et al.
Publicado: (2023)

Simultaneous robot-assisted surgery for rectal cancer and prostatic lesions
por: Kojima, Yutaka, et al.
Publicado: (2020)

Holmium laser enucleation of the prostate followed by high-intensity focused ultrasound treatment for patients with huge prostate adenoma and localized prostate cancer: 5-Year follow-up
por: Horiuchi, Akira, et al.
Publicado: (2016)

Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes
por: Nagata, Masayoshi, et al.
Publicado: (2016)

Autoimmune hemolytic anemia associated with renal urothelial cancer: A case report and literature review
por: Isotani, Shuji, et al.
Publicado: (2015)

Transcription factor 4 expression in circulating tumor cells from castration‐resistant prostate cancer
por: Nagaya, Naoya, et al.
Publicado: (2021)

Clinical Usefulness of Corticotropin Releasing Hormone Testing in Subclinical Cushing's Syndrome for Predicting Cortisol Replacement after Adrenalectomy
por: Inoue, Masahiro, et al.
Publicado: (2012)

Unexpected diagnosis of jejunal perforation after robot-assisted radical prostatectomy
por: Ishihara, Risa, et al.
Publicado: (2022)

Interferon-α Treatment for Growing Teratoma Syndrome of the Testis
por: Inoue, Masahiro, et al.
Publicado: (2013)

Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
por: Ide, Hisamitsu, et al.
Publicado: (2014)

Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy
por: Ohtaka, Ayako, et al.
Publicado: (2019)

Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy
por: Sakamoto, Yoshiro, et al.
Publicado: (2014)

Impact of Pretreatment Total Cholesterol Level Is Associated With Metastasis of Prostate Cancer
por: Hirano, Hisashi, et al.
Publicado: (2020)

Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer
por: Ide, Hisamitsu, et al.
Publicado: (2018)

Chemoprevention of Prostate Cancer: Soy Isoflavones and Curcumin
por: Horie, Shigeo
Publicado: (2012)

Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer
por: Ide, Hisamitsu, et al.
Publicado: (2013)

The role of hormone therapy and chemotherapy in oligometastatic prostate cancer
por: Miura, Yuji, et al.
Publicado: (2019)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia
por: Ieda, Takeshi, et al.
Publicado: (2016)

Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
por: Murray, Nigel P, et al.
Publicado: (2016)

The incidence, mortality, and risk factors of prostate cancer in Asian men
por: Ha Chung, Byung, et al.
Publicado: (2019)

Clinical studies investigating the use of leuprorelin for prostate cancer in Asia
por: Chung, Byung Ha, et al.
Publicado: (2020)

The Impact of Increased Bladder Blood Flow on Storage Symptoms after Holmium Laser Enucleation of the Prostate
por: Saito, Keisuke, et al.
Publicado: (2015)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
por: Yuh, Bertram E., et al.
Publicado: (2019)

Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
por: Nagao, Kazuhiro, et al.
Publicado: (2018)

Peritoneal dissemination of prostate cancer due to laparoscopic radical prostatectomy: a case report
por: Hiyama, Yoshiki, et al.
Publicado: (2011)

Radical Prostatectomy: An Option for High-Risk Prostate Cancer
por: Rausch, S., et al.
Publicado: (2012)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uahhu65rjahu1q88h4fcpaoe32